Background and Purpose: Elevated homocysteine (Hcy) plasma levels are associated with an increased risk of spontaneous cervical artery dissection (sCAD). We examined the potential association between Hcy, folate, vitamin B12 levels and 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms in patients with cerebral infarct caused by sCAD. Patients and Methods: 39 patients who survived a cerebral infarct caused by sCAD [20 (51%) women; 24 (61.5%) vertebral and 15 (38.5%) internal carotid arteries], and 76 healthy control subjects were included. Hcy plasma levels (fasting and after methionine load), folate and vitamin B12 levels were measured. We also performed polymorphisms of MTHFR. Hcy, vitamin B12, folates and polymorphisms of MTHFR were assessed and any associations were analyzed using multivariate statistics. Results: Mean plasma fasting Hcy level was 9.81 µmol/l for cases and 6.38 for controls (p = 0.001). The occurrence of sCAD was associated with elevated fasting Hcy levels (>95th percentile over the control group) with an adjusted odds ratio of 7.9 (95% CI 1.66–35). The association between low plasma folate values (<5th percentile) and the presence of CAD was 7.9 (95% CI 1.6–31) after adjusting for confounding variables. The distribution of the MTHFR genotype showed a higher TT mutant frequency among CAD patients (p = 0.034). Conclusions: High plasma concentrations of Hcy and low plasma levels of folate were associated with an increased risk of sCAD in the sample studied. We conclude that deficiencies in nutritional status may contribute to the relatively high incidence of CAD in Mexico.

Keywords:
Cervical artery dissection, Homocysteine, Folate, Vitamin B12
1.
Brandt T: Cervical artery dissection: update and new results of research of the pathogenesis. Cerebrovasc Dis 2000;10:5–8.
2.
Dziewas R, Konrad C, Drager B, Evers S, Besselmann M, Ludemann P, Kuhlenbaumer G, Stogbauer F, Ringelstein EB: Cervical artery dissections; clinical features, risk factors, therapy and outcome in 126 patients. J Neurol 2003;250:1179–1184.
3.
Barinagarrementeria F, Figueroa T, Huebe J, Cantú C: Cerebral Infarction in people under 40 years: etiologic analysis of 300 cases prospectively evaluated. Cerebrovasc Dis 1996;6:75–79.
4.
Arauz A, Hoyos L, Espinoza C, Cantú C, Barinagarrementeria F, Roman G: Dissection of the cervical arteries: long-term follow-up study of 130 consecutives cases. Cerebrovasc Dis 2006;22:150–154.
5.
Rubinstein SM, Peerdeman SM, van Tulder MW, Riphagen I, Haldeman S: A systematic review of the risk factors for cervical artery dissection. Stroke 2005;36:1575–1580.
6.
Guillon B, Bousser MG: Epidemiology and pathophysiology of spontaneous cervical artery dissection. J Neuroradiol 2002;29:241–249.
7.
Engelter ST, Lyrer PA, Kirsch EC, Steck AJ: Long-term follow-up after extracranial internal carotid artery dissection. Eur Neurol 2000;44:199–204.
8.
Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, Grassi M, Assanelli D, Gasparotti R, Vignolo LA, Magoni M, Padovani A: Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 2002;33:664–669.
9.
Konrad C, Müller GA, Langer C, Kuhlenbäumer G, Berger K, Nabavi DG, Dziewas R, Stögbauer F, Ringelstein EB, Junker R: Plasma homocysteine, MTHFR C677T, CBS 844ins68pb, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol 2004;251:1242–1248.
10.
Ubbink JB, Hayward WJ, Bissbort S: Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Cromatogr 1991;565:441–446.
11.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylentetrahydrofolate reductase. Nat Genet 1995;10:111–113.
12.
Beccia M, Mele MC, Ferrari M: Young stroke and basal plasma and post-methionine load homocysteine and cysteine levels 1 year after the acute event: do plasma folates make the difference? Eur J Neurol 2004;11:269–275.
13.
Galbussera A, Tremolizzo L, Longoni M, Facheris M, Tagliabue E, Appolonio I, Ferrarese C: Is elevated post-methionine load homocysteinaemia a risk factor for cervical artery dissection? Neurol Sci 2006;27:78–79.
14.
Gallai V, Caso V, Paciaroni M, Cardaioli G, Arning E, Bottiglieri T, Parnetti L: Mild hyperhomocyst(e)inemia. A possible risk factor for cervical artery dissection. Stroke 2001;32:714–718.
15.
Pezzini A, Del Zotto E, Padovani A: Hyperhomocysteinemia: a potential risk factor for cervical artery dissection following chiropractic manipulation of the cervical spine. J Neurol 2003;250:763–764.
16.
Choon-Kiat N, Venketasubramanian N, Saw S-M, Tjia H: Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults. Stroke 2002;33:1956–1962.
17.
Van Beynum IM, Smeitink JA, den Heijer M, te Poele Pothoff MT, Blom HJ: Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation 1999;99:2070–2072.
18.
Brand T, Grond-Ginsbach C: Spontaneous cervical artery dissection. From risk factors toward pathogenesis. Stroke 2002;33:657–658.
19.
Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson PW, Belanger AJ, O’Leary DH, et al: Association between plasma homocysteine concentrations and extracranial carotid stenosis. N Engl J Med 1995;332:286–291.
20.
Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence of causality from a meta-analysis. BMJ 2002;325:1202–1209.
21.
Howard VJ, Sides EG, Newman GC, Cohen SN, Howard G, Malinow R, Tool J: Changes in plasma homocysteine in the acute and after stroke. Stroke 2002;33:473–478.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.